For F&B investors and manufacturers, these natural offerings could provide an exciting opportunity to appeal to all, particularly amid GLP-1 side effect fears
Stojsavljevi A, Rovanin B, Krsti et al (2019) Evaluation of trace metals in thyroid tissues: comparative analysis with benign and malignant thyroid diseases
There are currently two anti-PCSK9 antibodies: alirocumab (trade name Praluent) and evolocumab (trade name Repatha) that are approved for use in hypercholesterolemia A third anti-PCSK9 monoclonal antibody, bococizumab, was in the process of development but was discontinued after reports of drawbacks including the formation of anti-drug antibodies, injection-site reactions, and significant variability in cholesterol-lowering effects (Ridker et al., 2017)
The post calls a slight energy dip during peak appetite suppression or on waking mild and usually self-limiting, and says moderate fatigue that interferes with work or exercise but improves with rest generally resolves as the body adapts
In functional medicine, growth hormone peptides and TRT are frequently prescribed concurrently
